ARTICLE | Company News
Agenix, Akzo Nobel NV deal
August 15, 2005 7:00 AM UTC
AKZ's Diosynth Biotechnology unit will manufacture AGX's ThromboView for Phase III trials and commercial sales. The radiolabeled monoclonal antibody is in Phase II testing as an imaging agent to detec...